Iso-Vet 1000 mg/g Inhalation Vapour, Liquid

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Isoflurane

Commercializzato da:

Piramal Healthcare UK Limited

Codice ATC:

QN01AB06

INN (Nome Internazionale):

Isoflurane

Forma farmaceutica:

Inhalation vapour, liquid

Tipo di ricetta:

POM-V - Prescription Only Medicine – Veterinarian

Gruppo terapeutico:

Cats, Chinchilla, Dogs, Ferrets, Gerbil, Guinea Pigs, Hamsters, Horses, Mice, Ornamental Birds, Rats, Reptiles

Area terapeutica:

Neurological Agent anaesthetic inhalation

Stato dell'autorizzazione:

Authorized

Data dell'autorizzazione:

2009-08-12

Scheda tecnica

Revised: August 2014
AN: 00874/2013
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Iso-Vet 1000 mg/g Inhalation Vapour, liquid (All CMS except Spain,
Portugal, Sweden, Denmark, Finland & Iceland)
IsoVet 1000 mg/g Inhalation Vapour, liquid (Spain & Portugal)
Attane vet 1000 mg/g Inhalation Vapour, liquid (Denmark, Sweden,
Finland & Iceland)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per gram:
Active Substance:
Isoflurane 1000 mg
The veterinary medicinal product contains no excipients.
3.
PHARMACEUTICAL FORM
Inhalation vapour, Liquid.
Clear, colourless, mobile, heavy liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters,
chinchillas, gerbils, guinea pigs and ferrets.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
Page 1 of 13
Revised: August 2014
AN: 00874/2013
4.3
CONTRA-INDICATIONS
This product should not be used in animals with a known sensitivity to
isoflurane
other
halogenated
inhalation
anesthetics
or
a
known
susceptibility to malignant hyperthermia.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The ease and rapidity of alteration of the depth of anaesthesia with
Isoflurane and its low metabolism, may be considered advantageous for
its use in special groups of patients such as the old or young, and
those
with impaired hepatic, renal or cardiac function.
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Isoflurane has little or no analgesic properties. Adequate analgesia
should
always be given before surgery. The analgesic requirements of the
patient
should be considered before general anaesthesia is ended.
The use of the product in patients with cardiac disease should be
considered only after a risk/ benefit assessment by the veterinarian.
It is important to monitor breathing and pulse for the frequency and
its
features. Respiratory arrest should be treated by assisted
ventilation. It is
important to maintain airways free and properl